Skip to main content
. 2019 Aug 6;93(6):e611–e623. doi: 10.1212/WNL.0000000000007892

Figure 2. Dentate nucleus (DN) hyperintensity on 3D-T1-weighted imaging in patients with multiple sclerosis (MS).

Figure 2

DN hyperintensity on 3D-T1-weighted imaging in patients with MS with 15 (A), 8 (B), and 4 (C) gadodiamide administered doses at baseline (top row) and at the follow-up (bottom row). (A) A 38-year-old man with relapsing-remitting MS (RRMS) whose signal intensity ratio (SIR) of DN to pons was 1.05 at baseline and 1.15 at the follow-up and shows bilateral hyperintensities in the DN region. (B) A 39-year-old woman with RRMS whose SIR was 1.01 at baseline and 1.07 at the follow-up and shows bilateral hyperintensities in the DN region. (C) A 41-year-old woman with RRMS whose SIR was 1.00 at baseline and is 1.01 at the follow-up and but does not show hyperintensities in the DN region.